Postradiation cutaneous angiosarcoma after treatment of breast carcinoma is characterized by MYC amplification in contrast to atypical vascular lesions after radiotherapy and control cases: Clinicopathological, immunohistochemical and molecular analysis of 66 cases

Modern Pathology

Volumn 25, Issue 1, 2012, Pages 75-85

  Mentzel, T ^a   Schildhaus, H U ^b   Palmedo, G ^a   Buttner R ^b   Kutzner, H ^a  

^a Dermatopathologie Bodensee   (Germany)

^b UNIVERSITY HOSPITAL OF COLOGNE   (Germany)

Author keywords

angiosarcoma; atypical vascular lesion; breast carcinoma; FISH; MYC

Indexed keywords

MYC PROTEIN; PROTEIN; PROX 1 PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANGIOSARCOMA; ARTICLE; ATYPICAL VASCULAR LESION; BENIGN LYMPHANGIOMATOUS PAPULE; BREAST CARCINOMA; CANCER RADIOTHERAPY; CELL PROLIFERATION; CONTROLLED STUDY; CUTANEOUS ANGIOSARCOMA; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HEMANGIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PAPULE; PRIORITY JOURNAL; PROCTITIS; PROTEIN EXPRESSION; RADIATION DERMATITIS; RADIATION INJURY; VASCULAR LESION;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CARCINOMA; CASE-CONTROL STUDIES; DIAGNOSIS, DIFFERENTIAL; FEMALE; GENE AMPLIFICATION; GERMANY; HEMANGIOSARCOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; NEOPLASMS, RADIATION-INDUCED; NEOVASCULARIZATION, PATHOLOGIC; PREDICTIVE VALUE OF TESTS; PROTO-ONCOGENE PROTEINS C-MYC; RADIOTHERAPY, ADJUVANT; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL; UP-REGULATION; YOUNG ADULT;

EID: 84855350839     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2011.134     Document Type: Article

References (20)

1. Diaz-Cascajo C, Borghi S, Weyers W, et al. Benign lymphangiomatous papules of the skin following radiotherapy: a report of five new cases and review of the literature. Histopathology 1999;35:319-327. (Pubitemid 29502350)
2. Requena L, Kutzner H, Mentzel T. Benign vascular proliferations in irradiated skin. Am J Surg Pathol 2002;26:328-337. (Pubitemid 34184456)
3. Fineberg S, Rosen PP. Cutaneous angiosarcoma and atypical vascular lesions of the skin and breast after radiation therapy for breast cancer. Am J Clin Pathol 1994;102:757-763.
4. Brenn T, Fletcher CDM. Postradiation vascular proliferations: an increasing problem. Histopathology 2006;48:106-114.
5. Santi R, Cetica V, Franchi A, et al. Tumour suppressor gene TP53 mutations in atypical vascular lesions of breast skin following radiotherapy. Histopathology 2011;58:455-466.
6. Manner J, Radlwimmer B, Hohenberger P, et al. MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema. Am J Pathol 2010;176:34-39.
7. Jackowski S, Janusch M, Fiedler E, et al. Radiogenic lymphangiogenesis in the skin. Am J Pathol 2007;171:338-348. (Pubitemid 47339250)
8. Weaver J, Billings SD. Postradiation cutaneous vascular tumors of the breast. A review. Sem Diagn Pathol 2009;26:141-149.
9. Gengler C, Coindre JM, Leroux A, et al. Vascular proliferations of the skin after radiation therapy for breast cancer: clinicopathologic analysis of a series in favour of a benign process. A study from the French Sarcoma Group. Cancer 2007;109:1584-1598. (Pubitemid 46595695)
10. Brenn T, Fletcher CDM. Radiation-associated cutaneous atypical vascular lesions and angiosarcoma clinicopathologic analysis of 42 cases. Am J Surg Pathol 2005;29:983-996. (Pubitemid 41045542)
11. Patton KT, Deyrup AT, Weiss SW. Atypical vascular lesions after surgery and radiation of the breast. A clinicopathologic study of 32 cases analyzing histologic heterogeneity and association with angiosarcoma. Am J Surg Pathol 2008;32:943-950.
12. Brooks TA, Hurley LH. The role of supercoiling in transcriptional control of MYC and its importance in molecular therapeutics. Nat Rev 2009;9:849-861.
13. Soucek L, Whitfield J, Martins CP, et al. Modelling Myc inhibition as a cancer therapy. Nature 2008;455:679-683.
14. Morrison C, Radmacher M, Mohammed N, et al. Myc amplification and polysomy 8 in chondrosarcoma: array comparative genomic hybridization, fluorescent in situ hybridization, and association with outcome. J Clin Oncol 2005;23:9369-9376.
15. Lualdi E, Modena P, Debiec-Rychter M, et al. Molecular cytogenetic characterization of proximal-type epithelioid sarcoma. Genes Chromosomes Cancer 2004;41:283-290. (Pubitemid 39299300)
16. Schneider-Stock R, Boltze C, Jager V, et al. Elevated telomerase activity, c-Myc, and hTERT mRNA expression in association with tumour progression in malignant lipomatous tumours. J Pathol 2003;199: 517-525. (Pubitemid 36416558)
17. Tsiatis AC, Herceg ME, Keedy VL, et al. Prognostic significance of c-Myc expression in soft tissue leiomyosarcoma. Mod Pathol 2009;22:1432-1438.
18. Guo T, Zhang L, Chang NE, et al. Consistent MYC and FLT4 gene amplification in radiation-induced angiosarcoma but not in other radiation-associated atypical vascular lesions. Genes Chromosomes Cancer 2011;50:25-33.
19. Rodriguez-Niedenfü hr M, Papoutsi M, Christ B, et al. Prox-1 is a marker of ectodermal placodes, endodermal compartments, lymphatic endothelium and lymphangioblasts. Anat Embyol 2002;204:399-406. (Pubitemid 33139877)
20. Hong YK, Harvey N, Noh YH, et al. Prox1 is a master control gene in the programm specifying lymphatic endothelial cell fate. Dev Dyn 2002;225:351-357. (Pubitemid 35265813)